Skip Ribbon Commands
Skip to main content
Chronic Malignancies


The CMWP promotes and conduct educational activities and clinical investigations on hematopoietic stem cell transplantation in chronic haematological malignancies. 

The CMWP consists of four subcommittees: 

  1. Chronic Myeloproliferative Disorders
  2. Chronic Lymphocytic Leukemia
  3. Plasma Cell Disorders
  4. Myelodysplastic Syndromes 

The mission of the CMWP is to contribute significantly to an improved  outcome of stem cell transplantation in chronic hematological malignancies by: 

  1. performing high quality retrospective registry studies
  2. performing prospective clinical trials and non-interventional studies (NIS)
  3. improving quality of data  in collaboration with other WP and the registry committee
  4. promoting advanced training and scientific interaction by performing “Educational Courses” and “Scientific Meetings”
  5. collaboration with national and international Transplant – and Non-transplant (disease-specific) Groups
  6. disseminating knowledge by up-to date information to the transplant and non-transplant scientific community, patient organization and lay public. 


CMWP Educational Event in cooperation with the Slovenia Hematology Association - "Impact of molecular mutation on transplant decision"

23 September 2017 in Ljubljana, Slovenia




CMWP Team 

Nicolaus Kröger

Stefan Schönland

Simona Iacobelli​
​Liesbeth de Wreede
Dimitris Ziagkos
Study Coordinator head
Anja van Biezen
Study Coordinators
​Jennifer Hoek
Anja Henseler
Linda Koster
Chairs / Vice-Chair of Plasma cell disorder subcommittee
Laurent Garderet
​Stefan Schönland
​Marie Robin ​
Theo de Witte
Chronic lymphocytic leukemia
Johannes Schetelig
​Michel van Gelder
Myeloproliferative neoplasias
Yves Chalandon
Eduardo Olavarria

List of Membersist of Members

Please click on this CMWP_memberlist_2013.xlsx to view the list of Members.

Related documents

Click HERE to view the publication list 


Studies Coordinated by the CMWP


Click HERE to view the Current Research list

  • Non-interventional prospective study on the on the effect of 2nd generation TKI prior to HSCT in CML
  • Non-interventional Study on alloHSCT in 17p-CLL
  • Non-interventional prospective study on iron toxicity in allogeneic transplanted MDS and CMML
  • Non-interventional prospective study on prognostic factors for autologous SCT outcomes in MM
  • CALM: Collaboration to collect Autologous transplant outcomes in Lymphoma and Myeloma
  • Plerifaxor Off-label Transplant Use
  • Data quality check in allogeneic CLL
  • Dose-reduced versus standard conditioning followed by allogeneic stem cell transplantation in patients with MDS or sAML: A randomised phase III study
  • Observational study on the use of B cell receptor kinase inhibitors and BCL2 antagonists prior to allogeneic hematopoietic stem cell transplantation for B cell malignancies: A joint project of the EBMT Lymphoma and Chronic Malignancy Working Parties.
  • Data quality check in MDS
  • Data quality check in MPN
  • Consensus on allogeneic SCT for MDS (in collaboration with ELN)
  • Consensus on allogeneic SCT for MPN (in collaboration with ELN)
  • Consensus on relapse after autografting in Multiple Myeloma (in collaboration with ASBMT, IWG MM, BMT-CTN)

How to get involved?

Please contact the Chairperson or the Secretary.



November 2017 | Vol. 59 - Issue 5 ... Read more >>
​vaccinations and CMV/HHV6 infections post-HSCT​...
The EBMT implements Elsevier’s MACRO platform to upgrade patient registry.... Read more >>
​More than 60 EBMT centres have already started entering their related donor data. We want to invite... Read more >>


Bookmark and Share